PPP1R1B and drug-induced dyskinesia: The hyperactivation of cAMP/PKA/DARPP-32 produced by l-DOPA in the dopamine-depleted striatum results in the dysregulation of multiple signaling pathways ultimately implicated in dyskinesia.